Drug Product
Company Overview
About
Ind-Swift is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Quality Control, Stability Testing, Method Development
Therapeutic Areas
Neurology
Quick Facts
HQ:India
Founded:2017
Employees:564
Capabilities & Services
Core Capabilities
- Cytotoxic / ADC Handling
- High-Potency API
- Sterile Fill/Finish
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Topical / Transdermal
Containment Capabilities
Cytotoxic / ADC Handling
Production Scales
Commercial Scale
Large Scale (Metric Ton+)
Markets Served
North America
International Regulatory
EU GMP Certificates
6
Regulatory Bodies
EMA/EudraGMDP
Regulatory Approvals
Drug Approval OAC954
EMA · #APR-8BRTKCAV · 2018-06-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-ZBKJX1LG
Issued: 2020-11-16
Expires: 2025-11-12
Health Canada GMP
Health Canada
Cert #: CERT-64WUK6U9
Issued: 2020-01-12
Expires: 2025-03-27
Loading CDMO intelligence...
Key facts about Ind-Swift
- Ind-Swift is headquartered in India.
- Ind-Swift was founded in 2017.
- Ind-Swift has 564 employees.
- Ind-Swift's capabilities include Cytotoxic / ADC Handling, High-Potency API and Sterile Fill/Finish.
Find CDMOs like Ind-Swift
Directory pages this company appears in, each with the full list of matching manufacturers.